nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—migraine—Prednisone—systemic scleroderma	0.232	0.508	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—systemic scleroderma	0.225	0.492	CpDpCtD
Acetylsalicylic acid—CYP2C8—Mometasone—systemic scleroderma	0.0412	0.145	CbGbCtD
Acetylsalicylic acid—SLC22A6—Captopril—systemic scleroderma	0.0317	0.112	CbGbCtD
Acetylsalicylic acid—ALB—Captopril—systemic scleroderma	0.027	0.0952	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—systemic scleroderma	0.0235	0.083	CbGbCtD
Acetylsalicylic acid—ALB—Mycophenolate mofetil—systemic scleroderma	0.0212	0.0749	CbGbCtD
Acetylsalicylic acid—ABCB1—Lisinopril—systemic scleroderma	0.0188	0.0665	CbGbCtD
Acetylsalicylic acid—CYP2C9—Leflunomide—systemic scleroderma	0.0185	0.0654	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—systemic scleroderma	0.017	0.0599	CbGbCtD
Acetylsalicylic acid—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0164	0.0579	CbGbCtD
Acetylsalicylic acid—ABCB1—Captopril—systemic scleroderma	0.0141	0.0498	CbGbCtD
Acetylsalicylic acid—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0392	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—systemic scleroderma	0.011	0.0388	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—systemic scleroderma	0.01	0.0353	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—systemic scleroderma	0.00888	0.0313	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—systemic scleroderma	0.00851	0.03	CbGbCtD
Acetylsalicylic acid—HSPA5—skeletal joint—systemic scleroderma	0.00818	0.113	CbGeAlD
Acetylsalicylic acid—CYP2C9—cardial valve—systemic scleroderma	0.00523	0.0721	CbGeAlD
Acetylsalicylic acid—TP53—manus—systemic scleroderma	0.00493	0.068	CbGeAlD
Acetylsalicylic acid—TP53—manual digit—systemic scleroderma	0.00482	0.0665	CbGeAlD
Acetylsalicylic acid—ABCB1—Methotrexate—systemic scleroderma	0.00445	0.0157	CbGbCtD
Acetylsalicylic acid—TP53—endothelium—systemic scleroderma	0.003	0.0414	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—systemic scleroderma	0.00295	0.0407	CbGeAlD
Acetylsalicylic acid—TP53—blood vessel—systemic scleroderma	0.00277	0.0382	CbGeAlD
Acetylsalicylic acid—NFKBIA—blood vessel—systemic scleroderma	0.00272	0.0375	CbGeAlD
Acetylsalicylic acid—PTGS2—skeletal joint—systemic scleroderma	0.00163	0.0225	CbGeAlD
Acetylsalicylic acid—TP53—connective tissue—systemic scleroderma	0.00142	0.0196	CbGeAlD
Acetylsalicylic acid—NFKBIA—connective tissue—systemic scleroderma	0.0014	0.0192	CbGeAlD
Acetylsalicylic acid—HSPA5—connective tissue—systemic scleroderma	0.00137	0.0189	CbGeAlD
Acetylsalicylic acid—TP53—smooth muscle tissue—systemic scleroderma	0.0013	0.0179	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—systemic scleroderma	0.00128	0.0177	CbGeAlD
Acetylsalicylic acid—NFKBIA—smooth muscle tissue—systemic scleroderma	0.00128	0.0176	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—systemic scleroderma	0.00126	0.0174	CbGeAlD
Acetylsalicylic acid—HSPA5—smooth muscle tissue—systemic scleroderma	0.00125	0.0172	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—systemic scleroderma	0.00123	0.017	CbGeAlD
Acetylsalicylic acid—RPS6KA3—connective tissue—systemic scleroderma	0.00116	0.0161	CbGeAlD
Acetylsalicylic acid—TP53—digestive system—systemic scleroderma	0.00102	0.0141	CbGeAlD
Acetylsalicylic acid—NFKBIA—digestive system—systemic scleroderma	0.00101	0.0139	CbGeAlD
Acetylsalicylic acid—HSPA5—digestive system—systemic scleroderma	0.000987	0.0136	CbGeAlD
Acetylsalicylic acid—TP53—tendon—systemic scleroderma	0.000975	0.0134	CbGeAlD
Acetylsalicylic acid—NFKBIA—tendon—systemic scleroderma	0.000959	0.0132	CbGeAlD
Acetylsalicylic acid—HSPA5—tendon—systemic scleroderma	0.00094	0.013	CbGeAlD
Acetylsalicylic acid—IKBKB—connective tissue—systemic scleroderma	0.00086	0.0119	CbGeAlD
Acetylsalicylic acid—TP53—lung—systemic scleroderma	0.000856	0.0118	CbGeAlD
Acetylsalicylic acid—NFKBIA—lung—systemic scleroderma	0.000842	0.0116	CbGeAlD
Acetylsalicylic acid—HSPA5—lung—systemic scleroderma	0.000825	0.0114	CbGeAlD
Acetylsalicylic acid—RPS6KA3—tendon—systemic scleroderma	0.0008	0.011	CbGeAlD
Acetylsalicylic acid—IKBKB—smooth muscle tissue—systemic scleroderma	0.000786	0.0108	CbGeAlD
Acetylsalicylic acid—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.000778	0.436	CbGdCrCtD
Acetylsalicylic acid—IKBKB—skin of body—systemic scleroderma	0.000776	0.0107	CbGeAlD
Acetylsalicylic acid—PTGS1—artery—systemic scleroderma	0.000716	0.00987	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lung—systemic scleroderma	0.000702	0.00968	CbGeAlD
Acetylsalicylic acid—PTGS2—artery—systemic scleroderma	0.000684	0.00944	CbGeAlD
Acetylsalicylic acid—EDNRA—tendon—systemic scleroderma	0.000651	0.00897	CbGeAlD
Acetylsalicylic acid—IKBKB—digestive system—systemic scleroderma	0.000621	0.00856	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—systemic scleroderma	0.000605	0.00834	CbGeAlD
Acetylsalicylic acid—SLC22A7—digestive system—systemic scleroderma	0.000602	0.0083	CbGeAlD
Acetylsalicylic acid—IKBKB—tendon—systemic scleroderma	0.000591	0.00815	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—systemic scleroderma	0.000578	0.00797	CbGeAlD
Acetylsalicylic acid—EDNRA—lung—systemic scleroderma	0.000571	0.00787	CbGeAlD
Acetylsalicylic acid—PTGS1—blood vessel—systemic scleroderma	0.000558	0.00769	CbGeAlD
Acetylsalicylic acid—TP53—Danazol—Prednisone—systemic scleroderma	0.000536	0.301	CbGdCrCtD
Acetylsalicylic acid—PTGS2—blood vessel—systemic scleroderma	0.000533	0.00735	CbGeAlD
Acetylsalicylic acid—IKBKB—lung—systemic scleroderma	0.000518	0.00715	CbGeAlD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000469	0.263	CbGdCrCtD
Acetylsalicylic acid—ABCB1—blood vessel—systemic scleroderma	0.00033	0.00455	CbGeAlD
Acetylsalicylic acid—CYP2C19—digestive system—systemic scleroderma	0.000292	0.00402	CbGeAlD
Acetylsalicylic acid—PTGS1—connective tissue—systemic scleroderma	0.000286	0.00394	CbGeAlD
Acetylsalicylic acid—Influenza—Lisinopril—systemic scleroderma	0.000281	0.0029	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Azathioprine—systemic scleroderma	0.000279	0.00288	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Azathioprine—systemic scleroderma	0.000277	0.00286	CcSEcCtD
Acetylsalicylic acid—PTGS2—connective tissue—systemic scleroderma	0.000273	0.00377	CbGeAlD
Acetylsalicylic acid—Chest pain—Mometasone—systemic scleroderma	0.000268	0.00277	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mometasone—systemic scleroderma	0.000268	0.00277	CcSEcCtD
Acetylsalicylic acid—Sweating—Mycophenolic acid—systemic scleroderma	0.000267	0.00275	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000265	0.00274	CcSEcCtD
Acetylsalicylic acid—Somnolence—Pentoxifylline—systemic scleroderma	0.000265	0.00273	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Leflunomide—systemic scleroderma	0.000263	0.00272	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Pentoxifylline—systemic scleroderma	0.000262	0.00271	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Leflunomide—systemic scleroderma	0.000262	0.0027	CcSEcCtD
Acetylsalicylic acid—PTGS1—smooth muscle tissue—systemic scleroderma	0.000262	0.00361	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00268	CcSEcCtD
Acetylsalicylic acid—PTGS1—skin of body—systemic scleroderma	0.000258	0.00356	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Mometasone—systemic scleroderma	0.000257	0.00265	CcSEcCtD
Acetylsalicylic acid—Anaemia—Captopril—systemic scleroderma	0.000255	0.00264	CcSEcCtD
Acetylsalicylic acid—Angioedema—Captopril—systemic scleroderma	0.000253	0.00261	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.000251	0.00259	CcSEcCtD
Acetylsalicylic acid—PTGS2—smooth muscle tissue—systemic scleroderma	0.00025	0.00345	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00025	0.00258	CcSEcCtD
Acetylsalicylic acid—Syncope—Captopril—systemic scleroderma	0.000248	0.00256	CcSEcCtD
Acetylsalicylic acid—PTGS2—skin of body—systemic scleroderma	0.000247	0.0034	CbGeAlD
Acetylsalicylic acid—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00254	CcSEcCtD
Acetylsalicylic acid—Influenza—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00254	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000245	0.00253	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Captopril—systemic scleroderma	0.000243	0.00251	CcSEcCtD
Acetylsalicylic acid—Sweating—Lisinopril—systemic scleroderma	0.00024	0.00248	CcSEcCtD
Acetylsalicylic acid—Urticaria—Pentoxifylline—systemic scleroderma	0.000236	0.00244	CcSEcCtD
Acetylsalicylic acid—Chest pain—Captopril—systemic scleroderma	0.000235	0.00243	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Captopril—systemic scleroderma	0.000235	0.00243	CcSEcCtD
Acetylsalicylic acid—Ulcer—Methotrexate—systemic scleroderma	0.000235	0.00243	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Mycophenolic acid—systemic scleroderma	0.000233	0.0024	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mometasone—systemic scleroderma	0.000229	0.00236	CcSEcCtD
Acetylsalicylic acid—Confusional state—Captopril—systemic scleroderma	0.000227	0.00235	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Methotrexate—systemic scleroderma	0.000226	0.00234	CcSEcCtD
Acetylsalicylic acid—CYP2C9—digestive system—systemic scleroderma	0.000226	0.00312	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Mometasone—systemic scleroderma	0.000226	0.00233	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Captopril—systemic scleroderma	0.000226	0.00233	CcSEcCtD
Acetylsalicylic acid—Anaemia—Azathioprine—systemic scleroderma	0.000223	0.0023	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Prednisone—systemic scleroderma	0.000222	0.00229	CcSEcCtD
Acetylsalicylic acid—Shock—Captopril—systemic scleroderma	0.000222	0.00229	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Captopril—systemic scleroderma	0.000221	0.00228	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Captopril—systemic scleroderma	0.00022	0.00227	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000219	0.00226	CcSEcCtD
Acetylsalicylic acid—Melaena—Methotrexate—systemic scleroderma	0.000217	0.00224	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Azathioprine—systemic scleroderma	0.000216	0.00223	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Prednisone—systemic scleroderma	0.000216	0.00223	CcSEcCtD
Acetylsalicylic acid—Pruritus—Pentoxifylline—systemic scleroderma	0.000211	0.00217	CcSEcCtD
Acetylsalicylic acid—Anaemia—Leflunomide—systemic scleroderma	0.000211	0.00217	CcSEcCtD
Acetylsalicylic acid—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00217	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Lisinopril—systemic scleroderma	0.00021	0.00217	CcSEcCtD
Acetylsalicylic acid—Flushing—Lisinopril—systemic scleroderma	0.000209	0.00216	CcSEcCtD
Acetylsalicylic acid—Angioedema—Leflunomide—systemic scleroderma	0.000208	0.00215	CcSEcCtD
Acetylsalicylic acid—PTGS1—digestive system—systemic scleroderma	0.000207	0.00285	CbGeAlD
Acetylsalicylic acid—Arthralgia—Azathioprine—systemic scleroderma	0.000205	0.00212	CcSEcCtD
Acetylsalicylic acid—Vertigo—Leflunomide—systemic scleroderma	0.000205	0.00211	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Leflunomide—systemic scleroderma	0.000204	0.00211	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000204	0.0021	CcSEcCtD
Acetylsalicylic acid—Coma—Methotrexate—systemic scleroderma	0.000203	0.0021	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Captopril—systemic scleroderma	0.000201	0.00208	CcSEcCtD
Acetylsalicylic acid—Anaemia—Mycophenolic acid—systemic scleroderma	0.000201	0.00207	CcSEcCtD
Acetylsalicylic acid—Somnolence—Captopril—systemic scleroderma	0.000201	0.00207	CcSEcCtD
Acetylsalicylic acid—Purpura—Prednisone—systemic scleroderma	0.0002	0.00207	CcSEcCtD
Acetylsalicylic acid—Agitation—Mycophenolic acid—systemic scleroderma	0.0002	0.00206	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Captopril—systemic scleroderma	0.000199	0.00205	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00204	CcSEcCtD
Acetylsalicylic acid—PTGS2—digestive system—systemic scleroderma	0.000197	0.00272	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000197	0.00203	CcSEcCtD
Acetylsalicylic acid—Dizziness—Pentoxifylline—systemic scleroderma	0.000197	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypertension—Leflunomide—systemic scleroderma	0.000197	0.00203	CcSEcCtD
Acetylsalicylic acid—PTGS1—tendon—systemic scleroderma	0.000197	0.00271	CbGeAlD
Acetylsalicylic acid—Vertigo—Mycophenolic acid—systemic scleroderma	0.000195	0.00202	CcSEcCtD
Acetylsalicylic acid—Syncope—Mycophenolic acid—systemic scleroderma	0.000195	0.00201	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000195	0.00201	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Leflunomide—systemic scleroderma	0.000194	0.002	CcSEcCtD
Acetylsalicylic acid—Chest pain—Leflunomide—systemic scleroderma	0.000194	0.002	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000193	0.00199	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000193	0.00199	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000191	0.00197	CcSEcCtD
Acetylsalicylic acid—Vomiting—Pentoxifylline—systemic scleroderma	0.000189	0.00195	CcSEcCtD
Acetylsalicylic acid—Convulsion—Mycophenolic acid—systemic scleroderma	0.000188	0.00194	CcSEcCtD
Acetylsalicylic acid—PTGS2—tendon—systemic scleroderma	0.000188	0.00259	CbGeAlD
Acetylsalicylic acid—Rash—Pentoxifylline—systemic scleroderma	0.000188	0.00194	CcSEcCtD
Acetylsalicylic acid—Hypertension—Mycophenolic acid—systemic scleroderma	0.000188	0.00194	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Pentoxifylline—systemic scleroderma	0.000188	0.00194	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000186	0.00192	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Captopril—systemic scleroderma	0.000186	0.00192	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000185	0.00192	CcSEcCtD
Acetylsalicylic acid—Chest pain—Mycophenolic acid—systemic scleroderma	0.000185	0.00191	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000185	0.00191	CcSEcCtD
Acetylsalicylic acid—Polyuria—Methotrexate—systemic scleroderma	0.000184	0.0019	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000184	0.0019	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000182	0.00188	CcSEcCtD
Acetylsalicylic acid—Pruritus—Mometasone—systemic scleroderma	0.000182	0.00188	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Leflunomide—systemic scleroderma	0.000181	0.00187	CcSEcCtD
Acetylsalicylic acid—Anaemia—Lisinopril—systemic scleroderma	0.000181	0.00187	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00018	0.00186	CcSEcCtD
Acetylsalicylic acid—Angioedema—Lisinopril—systemic scleroderma	0.000179	0.00185	CcSEcCtD
Acetylsalicylic acid—Confusional state—Mycophenolic acid—systemic scleroderma	0.000179	0.00185	CcSEcCtD
Acetylsalicylic acid—Nausea—Pentoxifylline—systemic scleroderma	0.000177	0.00183	CcSEcCtD
Acetylsalicylic acid—Vertigo—Lisinopril—systemic scleroderma	0.000176	0.00182	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mometasone—systemic scleroderma	0.000176	0.00181	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Prednisone—systemic scleroderma	0.000176	0.00181	CcSEcCtD
Acetylsalicylic acid—Syncope—Lisinopril—systemic scleroderma	0.000176	0.00181	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Lisinopril—systemic scleroderma	0.000175	0.00181	CcSEcCtD
Acetylsalicylic acid—Shock—Mycophenolic acid—systemic scleroderma	0.000174	0.0018	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000174	0.00179	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000173	0.00179	CcSEcCtD
Acetylsalicylic acid—PTGS1—lung—systemic scleroderma	0.000172	0.00238	CbGeAlD
Acetylsalicylic acid—Loss of consciousness—Lisinopril—systemic scleroderma	0.000172	0.00178	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000171	0.00177	CcSEcCtD
Acetylsalicylic acid—Chest pain—Lisinopril—systemic scleroderma	0.000167	0.00172	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Lisinopril—systemic scleroderma	0.000167	0.00172	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Leflunomide—systemic scleroderma	0.000166	0.00171	CcSEcCtD
Acetylsalicylic acid—PTGS2—lung—systemic scleroderma	0.000165	0.00227	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Leflunomide—systemic scleroderma	0.000164	0.00169	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mometasone—systemic scleroderma	0.000163	0.00169	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Azathioprine—systemic scleroderma	0.000162	0.00168	CcSEcCtD
Acetylsalicylic acid—Rash—Mometasone—systemic scleroderma	0.000162	0.00167	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mometasone—systemic scleroderma	0.000162	0.00167	CcSEcCtD
Acetylsalicylic acid—Confusional state—Lisinopril—systemic scleroderma	0.000161	0.00166	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00016	0.00165	CcSEcCtD
Acetylsalicylic acid—Pruritus—Captopril—systemic scleroderma	0.00016	0.00165	CcSEcCtD
Acetylsalicylic acid—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00164	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000158	0.00163	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mycophenolic acid—systemic scleroderma	0.000158	0.00163	CcSEcCtD
Acetylsalicylic acid—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00163	CcSEcCtD
Acetylsalicylic acid—Shock—Lisinopril—systemic scleroderma	0.000157	0.00162	CcSEcCtD
Acetylsalicylic acid—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00162	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000156	0.00162	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000156	0.00161	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Lisinopril—systemic scleroderma	0.000156	0.00161	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000154	0.00159	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Captopril—systemic scleroderma	0.000154	0.00159	CcSEcCtD
Acetylsalicylic acid—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00159	CcSEcCtD
Acetylsalicylic acid—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00159	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00159	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Leflunomide—systemic scleroderma	0.000153	0.00158	CcSEcCtD
Acetylsalicylic acid—Nausea—Mometasone—systemic scleroderma	0.000153	0.00158	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00156	CcSEcCtD
Acetylsalicylic acid—Dizziness—Captopril—systemic scleroderma	0.000149	0.00154	CcSEcCtD
Acetylsalicylic acid—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000149	0.00153	CcSEcCtD
Acetylsalicylic acid—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00153	CcSEcCtD
Acetylsalicylic acid—Urticaria—Leflunomide—systemic scleroderma	0.000148	0.00153	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000146	0.00151	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00151	CcSEcCtD
Acetylsalicylic acid—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00151	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Azathioprine—systemic scleroderma	0.000145	0.0015	CcSEcCtD
Acetylsalicylic acid—Vomiting—Captopril—systemic scleroderma	0.000143	0.00148	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Lisinopril—systemic scleroderma	0.000142	0.00147	CcSEcCtD
Acetylsalicylic acid—Rash—Captopril—systemic scleroderma	0.000142	0.00147	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Captopril—systemic scleroderma	0.000142	0.00147	CcSEcCtD
Acetylsalicylic acid—Somnolence—Lisinopril—systemic scleroderma	0.000142	0.00147	CcSEcCtD
Acetylsalicylic acid—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00146	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Lisinopril—systemic scleroderma	0.000141	0.00145	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00145	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—systemic scleroderma	0.000139	0.00144	CcSEcCtD
Acetylsalicylic acid—Shock—Mycophenolate mofetil—systemic scleroderma	0.000138	0.00142	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00142	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Leflunomide—systemic scleroderma	0.000137	0.00141	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00141	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000135	0.0014	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Azathioprine—systemic scleroderma	0.000135	0.00139	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—systemic scleroderma	0.000134	0.00139	CcSEcCtD
Acetylsalicylic acid—Nausea—Captopril—systemic scleroderma	0.000134	0.00138	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—systemic scleroderma	0.000134	0.00138	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Lisinopril—systemic scleroderma	0.000132	0.00136	CcSEcCtD
Acetylsalicylic acid—Pruritus—Leflunomide—systemic scleroderma	0.000132	0.00136	CcSEcCtD
Acetylsalicylic acid—Dizziness—Azathioprine—systemic scleroderma	0.00013	0.00134	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Leflunomide—systemic scleroderma	0.000127	0.00131	CcSEcCtD
Acetylsalicylic acid—Urticaria—Lisinopril—systemic scleroderma	0.000127	0.00131	CcSEcCtD
Acetylsalicylic acid—Pruritus—Mycophenolic acid—systemic scleroderma	0.000125	0.0013	CcSEcCtD
Acetylsalicylic acid—Vomiting—Azathioprine—systemic scleroderma	0.000125	0.00129	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000125	0.00129	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000124	0.00129	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—systemic scleroderma	0.000124	0.00128	CcSEcCtD
Acetylsalicylic acid—Rash—Azathioprine—systemic scleroderma	0.000124	0.00128	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Azathioprine—systemic scleroderma	0.000124	0.00128	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—systemic scleroderma	0.000124	0.00128	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00127	CcSEcCtD
Acetylsalicylic acid—Dizziness—Leflunomide—systemic scleroderma	0.000123	0.00127	CcSEcCtD
Acetylsalicylic acid—ABCB1—digestive system—systemic scleroderma	0.000122	0.00168	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000121	0.00125	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—systemic scleroderma	0.000119	0.00123	CcSEcCtD
Acetylsalicylic acid—Vomiting—Leflunomide—systemic scleroderma	0.000118	0.00122	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Lisinopril—systemic scleroderma	0.000118	0.00122	CcSEcCtD
Acetylsalicylic acid—Dizziness—Mycophenolic acid—systemic scleroderma	0.000117	0.00121	CcSEcCtD
Acetylsalicylic acid—Rash—Leflunomide—systemic scleroderma	0.000117	0.00121	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Leflunomide—systemic scleroderma	0.000117	0.00121	CcSEcCtD
Acetylsalicylic acid—Nausea—Azathioprine—systemic scleroderma	0.000117	0.00121	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000115	0.00119	CcSEcCtD
Acetylsalicylic acid—Pruritus—Lisinopril—systemic scleroderma	0.000113	0.00117	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000113	0.00116	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methotrexate—systemic scleroderma	0.000112	0.00116	CcSEcCtD
Acetylsalicylic acid—Rash—Mycophenolic acid—systemic scleroderma	0.000112	0.00115	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000112	0.00115	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—systemic scleroderma	0.000112	0.00115	CcSEcCtD
Acetylsalicylic acid—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00115	CcSEcCtD
Acetylsalicylic acid—Nausea—Leflunomide—systemic scleroderma	0.00011	0.00114	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Lisinopril—systemic scleroderma	0.000109	0.00113	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—systemic scleroderma	0.000107	0.00111	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—systemic scleroderma	0.000107	0.0011	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—systemic scleroderma	0.000106	0.0011	CcSEcCtD
Acetylsalicylic acid—Dizziness—Lisinopril—systemic scleroderma	0.000106	0.00109	CcSEcCtD
Acetylsalicylic acid—Nausea—Mycophenolic acid—systemic scleroderma	0.000105	0.00109	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—systemic scleroderma	0.000104	0.00108	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—systemic scleroderma	0.000104	0.00108	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—systemic scleroderma	0.000104	0.00107	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000103	0.00106	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—systemic scleroderma	0.000102	0.00106	CcSEcCtD
Acetylsalicylic acid—ABCB1—lung—systemic scleroderma	0.000102	0.00141	CbGeAlD
Acetylsalicylic acid—Vomiting—Lisinopril—systemic scleroderma	0.000102	0.00105	CcSEcCtD
Acetylsalicylic acid—Rash—Lisinopril—systemic scleroderma	0.000101	0.00104	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—systemic scleroderma	0.000101	0.00104	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Lisinopril—systemic scleroderma	0.000101	0.00104	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—systemic scleroderma	0.0001	0.00104	CcSEcCtD
Acetylsalicylic acid—Pruritus—Mycophenolate mofetil—systemic scleroderma	9.9e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—systemic scleroderma	9.9e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.58e-05	0.000989	CcSEcCtD
Acetylsalicylic acid—Nausea—Lisinopril—systemic scleroderma	9.49e-05	0.00098	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—systemic scleroderma	9.49e-05	0.00098	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisone—systemic scleroderma	9.33e-05	0.000964	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—systemic scleroderma	9.26e-05	0.000956	CcSEcCtD
Acetylsalicylic acid—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.26e-05	0.000956	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—systemic scleroderma	9.17e-05	0.000947	CcSEcCtD
Acetylsalicylic acid—Anaemia—Methotrexate—systemic scleroderma	8.98e-05	0.000927	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mycophenolate mofetil—systemic scleroderma	8.9e-05	0.000919	CcSEcCtD
Acetylsalicylic acid—Rash—Mycophenolate mofetil—systemic scleroderma	8.83e-05	0.000911	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—CD247—systemic scleroderma	8.82e-05	0.000998	CbGpPWpGaD
Acetylsalicylic acid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.82e-05	0.000911	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—BLK—systemic scleroderma	8.77e-05	0.000992	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Peptide ligand-binding receptors—CCL2—systemic scleroderma	8.75e-05	0.000989	CbGpPWpGaD
Acetylsalicylic acid—Vertigo—Methotrexate—systemic scleroderma	8.73e-05	0.000901	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—systemic scleroderma	8.7e-05	0.000898	CcSEcCtD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	8.58e-05	0.00097	CbGpPWpGaD
Acetylsalicylic acid—Convulsion—Methotrexate—systemic scleroderma	8.42e-05	0.000869	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—systemic scleroderma	8.35e-05	0.000862	CcSEcCtD
Acetylsalicylic acid—TP53—Spinal Cord Injury—TGFB1—systemic scleroderma	8.34e-05	0.000943	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	8.33e-05	0.000942	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Mycophenolate mofetil—systemic scleroderma	8.31e-05	0.000859	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—systemic scleroderma	8.27e-05	0.000854	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—systemic scleroderma	8.27e-05	0.000854	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—TNFAIP3—systemic scleroderma	8.26e-05	0.000934	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	8.26e-05	0.000934	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	8.19e-05	0.000926	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Leptin signaling pathway—NOS3—systemic scleroderma	8.15e-05	0.000922	CbGpPWpGaD
Acetylsalicylic acid—TP53—MAPK Signaling Pathway—IL1B—systemic scleroderma	8.09e-05	0.000915	CbGpPWpGaD
Acetylsalicylic acid—Confusional state—Methotrexate—systemic scleroderma	8e-05	0.000826	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—systemic scleroderma	7.93e-05	0.000819	CcSEcCtD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	7.83e-05	0.000885	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Prednisone—systemic scleroderma	7.82e-05	0.000807	CcSEcCtD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	7.77e-05	0.000879	CbGpPWpGaD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—systemic scleroderma	7.76e-05	0.000802	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—systemic scleroderma	7.67e-05	0.000792	CcSEcCtD
Acetylsalicylic acid—TP53—TGF-beta Signaling Pathway—TGFB1—systemic scleroderma	7.63e-05	0.000863	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CTLA4—systemic scleroderma	7.59e-05	0.000858	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	7.56e-05	0.000855	CbGpPWpGaD
Acetylsalicylic acid—Urticaria—Prednisone—systemic scleroderma	7.54e-05	0.000778	CcSEcCtD
Acetylsalicylic acid—HSPA5—Metabolism of proteins—MMP1—systemic scleroderma	7.53e-05	0.000851	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—IL1B—systemic scleroderma	7.32e-05	0.000828	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HSPG2—systemic scleroderma	7.3e-05	0.000826	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—AGE/RAGE pathway—MMP9—systemic scleroderma	7.25e-05	0.00082	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—RHOB—systemic scleroderma	7.23e-05	0.000818	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—CTLA4—systemic scleroderma	7.18e-05	0.000812	CbGpPWpGaD
Acetylsalicylic acid—Dyspnoea—Methotrexate—systemic scleroderma	7.07e-05	0.00073	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—CSK—systemic scleroderma	7.05e-05	0.000797	CbGpPWpGaD
Acetylsalicylic acid—Somnolence—Methotrexate—systemic scleroderma	7.05e-05	0.000728	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—SMAD7—systemic scleroderma	7.01e-05	0.000793	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Prednisone—systemic scleroderma	6.99e-05	0.000722	CcSEcCtD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—IL1A—systemic scleroderma	6.98e-05	0.000789	CbGpPWpGaD
Acetylsalicylic acid—Dyspepsia—Methotrexate—systemic scleroderma	6.98e-05	0.000721	CcSEcCtD
Acetylsalicylic acid—IKBKB—Leptin signaling pathway—IL1B—systemic scleroderma	6.94e-05	0.000785	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—NOS3—systemic scleroderma	6.93e-05	0.000784	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	6.91e-05	0.000781	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	6.87e-05	0.000776	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Prednisone—systemic scleroderma	6.71e-05	0.000693	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Disease—CD247—systemic scleroderma	6.63e-05	0.00075	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—CCL2—systemic scleroderma	6.63e-05	0.000749	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	6.58e-05	0.000744	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—RHOB—systemic scleroderma	6.57e-05	0.000743	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—RHOB—systemic scleroderma	6.57e-05	0.000743	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—EDN1—systemic scleroderma	6.53e-05	0.000739	CbGpPWpGaD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—systemic scleroderma	6.53e-05	0.000675	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—systemic scleroderma	6.49e-05	0.00067	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methotrexate—systemic scleroderma	6.3e-05	0.000651	CcSEcCtD
Acetylsalicylic acid—TP53—MAPK Signaling Pathway—TGFB1—systemic scleroderma	6.29e-05	0.000711	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Prednisone—systemic scleroderma	6.27e-05	0.000648	CcSEcCtD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	6.25e-05	0.000707	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HLA-DQB1—systemic scleroderma	6.25e-05	0.000706	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	6.22e-05	0.000704	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Metabolism of proteins—CCL2—systemic scleroderma	6.12e-05	0.000692	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CSK—systemic scleroderma	6.11e-05	0.000691	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—HSPG2—systemic scleroderma	6.11e-05	0.000691	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	6.05e-05	0.000684	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Prednisone—systemic scleroderma	6.03e-05	0.000623	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Immune System—IRF5—systemic scleroderma	6.02e-05	0.00068	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—IL1B—systemic scleroderma	6e-05	0.000678	CbGpPWpGaD
Acetylsalicylic acid—Rash—Prednisone—systemic scleroderma	5.98e-05	0.000618	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—systemic scleroderma	5.98e-05	0.000617	CcSEcCtD
Acetylsalicylic acid—HSPA5—Immune System—IL1A—systemic scleroderma	5.93e-05	0.000671	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-DQB1—systemic scleroderma	5.92e-05	0.000669	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	5.91e-05	0.000668	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—CD40LG—systemic scleroderma	5.9e-05	0.000667	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	5.88e-05	0.000665	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	5.87e-05	0.000663	CbGpPWpGaD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—systemic scleroderma	5.84e-05	0.000603	CcSEcCtD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	5.84e-05	0.00066	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Metabolism of proteins—MMP2—systemic scleroderma	5.82e-05	0.000658	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IRF8—systemic scleroderma	5.75e-05	0.00065	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ITGAM—systemic scleroderma	5.75e-05	0.00065	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD247—systemic scleroderma	5.75e-05	0.00065	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	5.74e-05	0.000649	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—TGFB1—systemic scleroderma	5.69e-05	0.000643	CbGpPWpGaD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	5.68e-05	0.000642	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Prednisone—systemic scleroderma	5.64e-05	0.000582	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SMAD7—systemic scleroderma	5.61e-05	0.000634	CbGpPWpGaD
Acetylsalicylic acid—Pruritus—Methotrexate—systemic scleroderma	5.61e-05	0.000579	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—CD40LG—systemic scleroderma	5.59e-05	0.000632	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SMAD7—systemic scleroderma	5.55e-05	0.000627	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CSK—systemic scleroderma	5.47e-05	0.000618	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—MMP1—systemic scleroderma	5.43e-05	0.000614	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—MMP2—systemic scleroderma	5.43e-05	0.000614	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	5.43e-05	0.000614	CbGpPWpGaD
Acetylsalicylic acid—Diarrhoea—Methotrexate—systemic scleroderma	5.43e-05	0.00056	CcSEcCtD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—RHOB—systemic scleroderma	5.42e-05	0.000613	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—TNFAIP3—systemic scleroderma	5.38e-05	0.000609	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IRF5—systemic scleroderma	5.38e-05	0.000608	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—CCL2—systemic scleroderma	5.36e-05	0.000606	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—BLK—systemic scleroderma	5.32e-05	0.000602	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	5.32e-05	0.000601	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	5.26e-05	0.000595	CbGpPWpGaD
Acetylsalicylic acid—Dizziness—Methotrexate—systemic scleroderma	5.24e-05	0.000541	CcSEcCtD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—IL1B—systemic scleroderma	5.18e-05	0.000586	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IRF8—systemic scleroderma	5.14e-05	0.000581	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD247—systemic scleroderma	5.14e-05	0.000581	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ITGAM—systemic scleroderma	5.14e-05	0.000581	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HSPG2—systemic scleroderma	5.11e-05	0.000578	CbGpPWpGaD
Acetylsalicylic acid—Vomiting—Methotrexate—systemic scleroderma	5.04e-05	0.000521	CcSEcCtD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—IL1B—systemic scleroderma	5.02e-05	0.000568	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SMAD7—systemic scleroderma	5.02e-05	0.000567	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SMAD7—systemic scleroderma	5.02e-05	0.000567	CbGpPWpGaD
Acetylsalicylic acid—Rash—Methotrexate—systemic scleroderma	5e-05	0.000516	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—systemic scleroderma	4.99e-05	0.000516	CcSEcCtD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	4.99e-05	0.000565	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CSK—systemic scleroderma	4.94e-05	0.000558	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	4.92e-05	0.000557	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	4.88e-05	0.000552	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—TNFAIP3—systemic scleroderma	4.81e-05	0.000544	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—BLK—systemic scleroderma	4.76e-05	0.000538	CbGpPWpGaD
Acetylsalicylic acid—Nausea—Methotrexate—systemic scleroderma	4.71e-05	0.000486	CcSEcCtD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—TGFB1—systemic scleroderma	4.66e-05	0.000527	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	4.64e-05	0.000525	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—CTGF—systemic scleroderma	4.63e-05	0.000524	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—TGFB1—systemic scleroderma	4.59e-05	0.000519	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CSK—systemic scleroderma	4.48e-05	0.000507	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—CCL2—systemic scleroderma	4.47e-05	0.000505	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD247—systemic scleroderma	4.39e-05	0.000496	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ITGAM—systemic scleroderma	4.39e-05	0.000496	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CTLA4—systemic scleroderma	4.36e-05	0.000493	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—RHOB—systemic scleroderma	4.34e-05	0.000491	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—RHOB—systemic scleroderma	4.29e-05	0.000485	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—CCL2—systemic scleroderma	4.26e-05	0.000481	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	4.24e-05	0.000479	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD247—systemic scleroderma	4.21e-05	0.000476	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	4.16e-05	0.00047	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TNFAIP3—systemic scleroderma	4.11e-05	0.000465	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HSPG2—systemic scleroderma	4.09e-05	0.000463	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—MMP9—systemic scleroderma	4.08e-05	0.000461	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IL1B—systemic scleroderma	4.06e-05	0.000459	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HSPG2—systemic scleroderma	4.05e-05	0.000458	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.02e-05	0.000455	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.99e-05	0.000451	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CSK—systemic scleroderma	3.95e-05	0.000447	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—NOS3—systemic scleroderma	3.94e-05	0.000445	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CSK—systemic scleroderma	3.91e-05	0.000442	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—BLK—systemic scleroderma	3.9e-05	0.000441	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CTLA4—systemic scleroderma	3.89e-05	0.00044	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—RHOB—systemic scleroderma	3.88e-05	0.000439	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—RHOB—systemic scleroderma	3.88e-05	0.000439	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—MMP2—systemic scleroderma	3.87e-05	0.000438	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—EDN1—systemic scleroderma	3.69e-05	0.000418	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HSPG2—systemic scleroderma	3.66e-05	0.000414	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HSPG2—systemic scleroderma	3.66e-05	0.000414	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—IL1B—systemic scleroderma	3.64e-05	0.000412	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-DQB1—systemic scleroderma	3.59e-05	0.000406	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CSK—systemic scleroderma	3.53e-05	0.0004	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CSK—systemic scleroderma	3.53e-05	0.0004	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1A—systemic scleroderma	3.41e-05	0.000385	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD40LG—systemic scleroderma	3.39e-05	0.000383	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EDN1—systemic scleroderma	3.35e-05	0.000379	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EDN1—systemic scleroderma	3.35e-05	0.000379	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.23e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SELP—systemic scleroderma	3.22e-05	0.000364	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DQB1—systemic scleroderma	3.21e-05	0.000363	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CTLA4—systemic scleroderma	3.19e-05	0.000361	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.19e-05	0.000361	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	3.15e-05	0.000357	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL1B—systemic scleroderma	3.09e-05	0.00035	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	3.08e-05	0.000349	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.05e-05	0.000345	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1A—systemic scleroderma	3.05e-05	0.000344	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD40LG—systemic scleroderma	3.03e-05	0.000343	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—RHOB—systemic scleroderma	3.01e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	2.97e-05	0.000336	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—MMP9—systemic scleroderma	2.91e-05	0.000329	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TGFB1—systemic scleroderma	2.83e-05	0.00032	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EDN1—systemic scleroderma	2.77e-05	0.000313	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—CSK—systemic scleroderma	2.74e-05	0.00031	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CSK—systemic scleroderma	2.72e-05	0.000307	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet degranulation—TGFB1—systemic scleroderma	2.71e-05	0.000306	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IRF5—systemic scleroderma	2.67e-05	0.000302	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DQB1—systemic scleroderma	2.63e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—TGFB1—systemic scleroderma	2.6e-05	0.000294	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.6e-05	0.000294	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.58e-05	0.000292	CbGpPWpGaD
Acetylsalicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	2.58e-05	0.000292	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—ITGAM—systemic scleroderma	2.58e-05	0.000291	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IRF8—systemic scleroderma	2.56e-05	0.000289	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD247—systemic scleroderma	2.56e-05	0.000289	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ITGAM—systemic scleroderma	2.56e-05	0.000289	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SMAD7—systemic scleroderma	2.49e-05	0.000282	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD40LG—systemic scleroderma	2.48e-05	0.000281	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	2.45e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.42e-05	0.000274	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	2.42e-05	0.000274	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NOS3—systemic scleroderma	2.41e-05	0.000272	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TGFB1—systemic scleroderma	2.4e-05	0.000271	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	2.4e-05	0.000271	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TNFAIP3—systemic scleroderma	2.39e-05	0.000271	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—BLK—systemic scleroderma	2.36e-05	0.000267	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SMAD7—systemic scleroderma	2.33e-05	0.000263	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.32e-05	0.000262	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CCL2—systemic scleroderma	2.29e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CCL2—systemic scleroderma	2.29e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EDN1—systemic scleroderma	2.22e-05	0.000251	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EDN1—systemic scleroderma	2.19e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFBI—systemic scleroderma	2.13e-05	0.000241	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.11e-05	0.000239	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—NOS3—systemic scleroderma	2.02e-05	0.000228	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EDN1—systemic scleroderma	1.98e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EDN1—systemic scleroderma	1.98e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.97e-05	0.000223	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.96e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTLA4—systemic scleroderma	1.94e-05	0.000219	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RHOB—systemic scleroderma	1.93e-05	0.000218	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCL2—systemic scleroderma	1.89e-05	0.000214	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HSPG2—systemic scleroderma	1.82e-05	0.000206	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—HSPG2—systemic scleroderma	1.79e-05	0.000203	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1B—systemic scleroderma	1.78e-05	0.000201	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CSK—systemic scleroderma	1.76e-05	0.000199	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.76e-05	0.000199	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HSPG2—systemic scleroderma	1.7e-05	0.000192	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NOS3—systemic scleroderma	1.69e-05	0.000191	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.67e-05	0.000189	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CSK—systemic scleroderma	1.64e-05	0.000185	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.6e-05	0.000181	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQB1—systemic scleroderma	1.6e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TGFB1—systemic scleroderma	1.59e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1B—systemic scleroderma	1.59e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD247—systemic scleroderma	1.54e-05	0.000174	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1A—systemic scleroderma	1.52e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCL2—systemic scleroderma	1.51e-05	0.000171	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD40LG—systemic scleroderma	1.51e-05	0.00017	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCL2—systemic scleroderma	1.5e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—HSPG2—systemic scleroderma	1.42e-05	0.000161	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CTGF—systemic scleroderma	1.36e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCL2—systemic scleroderma	1.35e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCL2—systemic scleroderma	1.35e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MMP9—systemic scleroderma	1.35e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NOS3—systemic scleroderma	1.35e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NOS3—systemic scleroderma	1.33e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MMP1—systemic scleroderma	1.29e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOS3—systemic scleroderma	1.21e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOS3—systemic scleroderma	1.21e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.2e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.18e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HSPG2—systemic scleroderma	1.16e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HSPG2—systemic scleroderma	1.15e-05	0.00013	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TGFB1—systemic scleroderma	1.12e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP9—systemic scleroderma	1.08e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CTGF—systemic scleroderma	1.08e-05	0.000122	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP9—systemic scleroderma	1.07e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HSPG2—systemic scleroderma	1.03e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.01e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EDN1—systemic scleroderma	9.85e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP9—systemic scleroderma	9.68e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP9—systemic scleroderma	9.68e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HSPG2—systemic scleroderma	9.41e-06	0.000106	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS3—systemic scleroderma	9.36e-06	0.000106	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFB1—systemic scleroderma	8.93e-06	0.000101	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFB1—systemic scleroderma	8.83e-06	9.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CTGF—systemic scleroderma	8.77e-06	9.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CTGF—systemic scleroderma	8.72e-06	9.86e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFB1—systemic scleroderma	7.98e-06	9.03e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFB1—systemic scleroderma	7.98e-06	9.03e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—systemic scleroderma	7.9e-06	8.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CTGF—systemic scleroderma	7.83e-06	8.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CTGF—systemic scleroderma	7.64e-06	8.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CTGF—systemic scleroderma	7.14e-06	8.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL2—systemic scleroderma	6.74e-06	7.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—systemic scleroderma	6.19e-06	7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOS3—systemic scleroderma	6e-06	6.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NOS3—systemic scleroderma	5.91e-06	6.68e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS3—systemic scleroderma	5.6e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—systemic scleroderma	4.82e-06	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NOS3—systemic scleroderma	4.69e-06	5.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—systemic scleroderma	3.97e-06	4.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NOS3—systemic scleroderma	3.82e-06	4.32e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NOS3—systemic scleroderma	3.79e-06	4.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—systemic scleroderma	3.7e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NOS3—systemic scleroderma	3.41e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NOS3—systemic scleroderma	3.32e-06	3.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NOS3—systemic scleroderma	3.11e-06	3.51e-05	CbGpPWpGaD
